WEBSITECHANGES

Website Changes

---

09/24/2023

Brain Tumors in United States Military Veterans

---

09/24/2023

Peptide vaccine targets H3K27M mutation in midline gliomas, shows promise in early trials

---

09/18/2023

Real-world validity of randomized controlled phase III trials in newly diagnosed glioblastoma: to whom do the results of the trials apply?

---

09/16/2023

FDA expands approval of Temodar to treat additional form of brain cancer

---

09/14/2023

Deep vein thrombosis as a side effect of cancer: 9 things to know??

---

09/14/2023

xCures Platform advances progress on the White House Cancer Moonshot mission to end cancer as we know it.

---

09/11/2023

Cancer Chomp: A Brain Tumor Event in Gainesville, FL

---

09/11/2023

Study shows how microdevices can be used to treat brain cancer

---

08/29/2023

Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application

---

08/29/2023

Journey of pediatric brain tumor tissue donation

---

08/26/2023

Update on the Promising Pathway Act

---

08/26/2023

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis

---

08/26/2023

Prodrug-loaded semiconducting polymer hydrogels for deep-tissue sono-immunotherapy of orthotopic glioblastoma

---

08/23/2023

Estrogen-negative cancers respond to anti-estrogenic therapies

---

08/19/2023

Optune Open House in Tarrytown, NY Sept 12th, 2023.

---

08/18/2023

Using the Body’s `Invisible Scalpel` to Remove Brain Cancer With Immunotherapy at Salk Institute

---

08/18/2023

Scientists Find New Weapon Against Brain Tumor: `Major Crack in the Armor`

---

08/12/2023

Plus Therapeutics Reports ReSPECT-LM Phase 1 Trial Data at the 2023 SNO/ASCO CNS Cancer Conference

---

08/12/2023

She went to Germany for a new brain cancer treatment. She wonders why she had to learn about it online

---

08/10/2023

Perlmutter Cancer Center Enrolls First Participant in Study of Noninvasive Treatment of Glioblastoma

---

08/07/2023

GT Medical Technologies Marks a Clinical Milestone: 200th Patient Enrolled in the Multicenter Observational Registry of GammaTile® Therapy

---

08/02/2023

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

---

07/27/2023

Musella Foundation Copay Program now closed to new and renewal patients

---

07/26/2023

Hackensack Meridian Neuroscience Institute Now Using QuicktomeTM Brain Mapping Technology To Maximize Patient Outcomes By Allowing Neurosurgeons To Visualize Key Areas of the Brain Related To Speech and Other Key Functions During Complex Brain Surgery

---

07/26/2023

United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma

---